Who makes Part 2: Aerosol Spray?

Part 2: Aerosol Spray is developed by Food and Drug Administration (FDA).

What development phase is Part 2: Aerosol Spray in?

Part 2: Aerosol Spray is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Part 2: Aerosol Spray

Food and Drug Administration (FDA) · Phase 1 active Small molecule

At a glance

Generic name	Part 2: Aerosol Spray
Also known as	Avobenzone, Oxybenzone, Octocrylene, Homosalate, Octisalate
Sponsor	Food and Drug Administration (FDA)
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Assessment of the Human Systemic Absorption of Sunscreen Ingredients (PHASE1)
A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2) (PHASE1)
A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Part 2: Aerosol Spray CI brief — competitive landscape report
Part 2: Aerosol Spray updates RSS · CI watch RSS
Food and Drug Administration (FDA) portfolio CI